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Abstract
Hemiplegic migraines (HM) are a rare type of migraine with an aura phase that includes muscle
weakness. This form of migraine can either occur sporadically or can be seen in patients with familial
hemiplegic migraine which is an autosomal dominant subtype that runs in families. Migraines are
classically accompanied by phonophobia, photophobia, neurological symptoms, nausea or vomiting. The
subcategory of hemiplegic migraine involves a transient wave of motor weakness and muscle spasms
secondary to decreased threshold of excitation in the neurologic system. The etiology of Hemiplegic
Migraines is either idiopathic condition or genetic mutation in the CACNA1A, ATP1A2 and SCN1A
encoding proteins involved in ion transport. Our case outlines a 72 year old Caucasian female with past
medical history of transient ischemic attack (TIA) and paroxysmal atrial fibrillation, presenting to the
emergency department with sudden onset of headache, slurred speech and numbness and tingling in the
left hand and leg. Tissue plasminogen activor t-PA) was administered within the 45 minute window, and a
computed tomography angiography(CTA) of the head and neck was negative. Diagnosis of Hemiplegic
Migraine was suggestive given the neurologic signs and symptoms with negative neurologic imaging. The
expedited movement of neuronal depolarization down the easily excitable neurons causes a high
amplitude wave of energy down the muscle fibers. Other hemiparesis syndrome differentials include
MELAS, hereditary hemorrhagic telangiectasia, amyloidosis, and familial infantile convulsions. This case
highlights the rarity of hemiplegic migraines and although genetic testing was not performed in our
patient, it has been shown that some patients have a genetic predisposition. Strong clinical skills are
needed to match the concurrent neurologic symptoms with migraines.
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Hemiplegic Migraines; A Barrage on the Mind
Ganesh Arun*, Omar Siddiqui, Ellen Sampson, Adnaan Sheikh,
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Abstract
Hemiplegic migraines (HM) are a rare type of migraine with an aura phase that includes muscle weakness. This form of
migraine can either occur sporadically or can be seen in patients with familial hemiplegic migraine which is an autosomal
dominant subtype that runs in families. Migraines are classically accompanied by phonophobia, photophobia, neurological symptoms, nausea or vomiting. The subcategory of hemiplegic migraine involves a transient wave of motor
weakness and muscle spasms secondary to decreased threshold of excitation in the neurologic system. The etiology of
Hemiplegic Migraines is either idiopathic condition or genetic mutation in the CACNA1A, ATP1A2 and SCN1A encoding
proteins involved in ion transport. Our case outlines a 72 year old Caucasian female with past medical history of transient
ischemic attack (TIA) and paroxysmal atrial ﬁbrillation, presenting to the emergency department with sudden onset of
headache, slurred speech and numbness and tingling in the left hand and leg. Tissue plasminogen activor t-PA) was
administered within the 45 min window, and a computed tomography angiography (CTA) of the head and neck was
negative. Diagnosis of Hemiplegic Migraine was suggestive given the neurologic signs and symptoms with negative
neurologic imaging. The expedited movement of neuronal depolarization down the easily excitable neurons causes a high
amplitude wave of energy down the muscle ﬁbers. Other hemiparesis syndrome differentials include MELAS, hereditary
hemorrhagic telangiectasia, amyloidosis, and familial infantile convulsions. This case highlights the rarity of hemiplegic
migraines and although genetic testing was not performed in our patient, it has been shown that some patients have a
genetic predisposition. Strong clinical skills are needed to match the concurrent neurologic symptoms with migraines.
Keywords: Hemiplegic migraines, Headache

1. Introduction

H

emiplegic migraines (HM) are a rare type of
migraine with an aura phase that includes
muscle weakness. This form of migraine can either
occur sporadically or can be seen in patients with
familial hemiplegic migraine, a familial autosomal
dominant subtype. While migraines are common
disorders affecting approximately 15%e20% of the
population, hemiplegic migraines are rare occurrences with a prevalence of 0.01%.1 The motor auras
seen in these migraines are thought to be caused by
a self-propagating wave of neuronal and glial depolarization resulting in cortical depression.2
Studies have shown that these attacks are more
common in women with an average age of onset of
12 and 17 years old.1

2. Case presentation
A 72 year old Caucasian female with past medical
history (PMH) of multiple episodes of TIA, paroxysmal atrial ﬁbrillation, orthostatic hypotension, and
hypertension presented to the ED with sudden
onset of a headache without radiation or laterality,
numbness and tingling in the ﬁngers of her left
hand, weakness in the left leg, left sided facial
droop, and slurred speech. On admission vitals
were: Temperature 97.3 F, HR 55 beats per minute,
RR: 12 per minute, BP: 151/54, Oxygen Saturation
100% on room air. Her National Institute of Health
(NIH) stroke scale score was 8.
On physical examination, muscle strength was 4þ
in the left upper and lower extremities. Left facial
droop was conﬁrmed. Cranial nerve VII deﬁcits were
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noted and the patient could not smile, frown, or puff
out her cheeks. Forehead was spared and facial
sensation was intact. The Biceps, brachioradialis,
triceps, patellar, and Achilles reﬂexes were tested
and were globally 1þ on the left side and 2þ on the
right side. CT head showed no acute intracranial
abnormalities. CTA head revealed no sign of dural
sinus thrombosis or signiﬁcant intracranial venous or
arterial abnormalities. CTA neck showed minimal
left greater than right atherosclerotic plaque formation in the bilateral carotid bulbs, without hemodynamically signiﬁcant stenosis. Posterior venous
abnormalities, while possible, were considered unlikely given her symptoms. As the patient arrived
within the tPA window, and no obvious bleed was
seen on the CTA head, alteplase was administered in
the Emergency Department. However, this intervention resulted in only minimal improvement.
Patient stated that she was admitted for a similar
event in 2017, for which she also received IV tPA.
That event was not associated with headaches.
Echocardiogram performed then and at the time of
this admission showed normal cavity size, atrial
septa, wall thickness, diastolic parameters, and left
ventricular ejection fraction with no regional wall
motion abnormalities (Table 1).
The patient was admitted for cerebral infarction
due to unspeciﬁed occlusion or stenosis of the
basilar arteries, and also diagnosed with hemiplegic
migraine given neurologic signs and symptoms with
negative neuro imaging ﬁndings. Following admission she was started on Topiramate 25 mg po BID
for one week and then increased to 50 mg po BID
with resolution of migrainous symptoms.
Table 1. Labs at the time of this admission.
CBC:
White Count: 8.5 (ref: 4e10 x 10^3 uL)
Hemoglobin: 12.6 (ref:11.6e15.2 g/dL)
MCV: 90.9 (ref: 80e97 FL)
Platelets: 254,000 (ref: 150,000e450,000)
CMP:
Sodium: 142 (ref: 136e145 mmol/L)
Potassium: 3.8 (ref: 3.5e5.1 mmol/L)
Chloride: 108 (ref: 98e107 mmol/L)
Bicarbonate: 26 (ref: 21e31 mmol/L)
BUN: 17 (ref: 7e25 mg/dL)
Creatinine: 0.7 (ref: 0.6e1.2 mg/dL)
Lipid Proﬁle:
Cholesterol: 141 (ref: <200 mg/dL)
Triglycerides: 203 (ref: 0e150 mg/dL)
HDL: 35 (ref: > 39.9 mg/dL)
LDL (calculated): 65 (ref: <100 mg/dL)
APTT: 35.8 (ref: 22.9e36.5 s)
PT: 11.8 (ref: 11.0e14.6 s)
INR: 0.9 (ref: 0.8e1.2)
HbA1c: 5.8 (ref: 4.0e6.0%)
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3. Discussion
Migraines are classically accompanied by phonophobia, photophobia, neurological symptoms,
nausea or vomiting. The subcategory of hemiplegic
migraine (HM) involves a transient wave of motor
weakness and muscle spasms secondary to
decreased threshold of excitation in the neurologic
system.3 Hemiplegic migraine is a rare and complex
disease, characterized by migraine with a reversible
motor aura. Motor symptoms usually last for hours
to days with a spectrum of visual, sensory, or
possibly speech impairments. The etiology of this
disorder is either idiopathic or genetic mutation in
the CACNA1A, ATP1A2 and SCN1A encoding
proteins involved in ion transport. The expedited
movement of neuronal depolarization down the
easily excitable neurons causes a high amplitude
wave of energy down the muscle ﬁbers. In the genetic form, exacerbations start in the ﬁrst to second
decade of life.
Differentiation of classical migraine from HM is
the type of aura. A migraine aura usually presents
with visual symptoms, however motor symptoms
are uncommon. In HM, the aura is characterized by
the presence of motor weakness, often accompanied by impairments in vision, speech, and sensation. Our patient presented with recurrent
headaches associated with aphasia, numbness, and
weakness, thus consistent with the presentation of
HM auras.
Neuroimaging, cerebrospinal ﬂuid analysis, and
electroencephalography are useful but the diagnosis is clinical with the aid of genetic conﬁrmation.4 If undiagnosed, HM may be mistaken for
epilepsy due to its tendency to recur along with the
fact that auras seen in HM present similar to postictal (Todd) paralysis. The aura in hemiplegic migraines can include visual symptoms which are
almost never seen in epilepsy, allowing for some
differentiation when present. The duration of
symptoms seen in HM is approximately 60 min,
much longer than is typically seen in epilepsy.
Other hemiparesis syndrome differentials need to
be excluded as well.5 These include mitochondrial
encephalopathy, lactic acidosis, and stroke-like
episodes (MELAS Syndrome), hereditary hemorrhagic telangiectasia (HHT), amyloidosis, and familial infantile convulsions. MELAS syndrome
usually presents in individuals between the ages of
2e15 years with deﬁnitive diagnosis obtained via
genetic testing or muscle biopsy showing many
ragged red ﬁbers.6 HHT usually presents with
signs of bleeding including nose bleeds, telangiectasias on the lips and oral mucosa, and
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hemorrhages in the gastrointestinal system, or
brain.7 Amyloidosis can present as a headache, loss
of consciousness and vomiting; long term complications of this disease also includes dementia.8
Lastly, familial infantile convulsions usually presents with convulsions between 3 and 8 months of
life with clusters of brief seizures lasting only
3e5 min over a few days.9
A complication of HM is permanent brain damage and atrophy as well as cognitive deterioration
in a stepwise developmental pattern. Neuroimaging can reveal small white matter lesions or
demyelination.

4. Conclusion
This case highlights the rarity of hemiplegic migraines and the genetic predisposition in these patients. Strong clinical skills are needed to match the
concurrent neurologic symptoms with migraines.
This patient received tPA for a presumed strokedtwice. One way to differentiate between hemiplegic migraines and stroke is to note the onset of
symptoms. Rapid onset of symptoms suggests a
stroke. However, if symptom onset is slower it is
more likely to be a hemiplegic migraine. Deducing
when the symptoms ﬁrst started can also differentiate HM from a stroke. Hemiplegic migraines
usually present in the ﬁrst few decades of life
whereas a stroke is more likely to occur in individuals over 50 years of age. Lifestyle habits
should also be evaluated as poor dietary habits, low
exercise, alcohol and smoking can increase the risk
of stroke.10
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